Form D · Biotechnology
Kailos Genetics, Inc.
Huntsville, AL · CIK 0001503871
Offering snapshot reported Apr 17, 2018 · SEC filing
- Reported sold
- $1.98M Offering amount: $2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 17, 2018 | Initial | $1,975,000 | No comparison | 8 | SEC filing |
| Nov 16, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 26, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 1, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 1, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 20, 2011 | Initial | $1,900,000 | No comparison | 4 | SEC filing |
| Oct 21, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-310390
Convertible debentures and preferred stock issuable upon conversion of convertible debentures
Source: Form D, filed Apr 17, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Randall C. Bachmeyer | Executive |
| James Hudson | Director |
| James R. Hudson, Jr. | Director |
| David Troy Moore | Director, Executive |
| Kenneth Noonan | Director |
| Brian K. Pollock | Director, Executive |
| Katherine T. Varley | Director |
| Cheri Walker | Executive |
| Michael J. Walters | Director |
| Danny Windham | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
601 Genome Way
Huntsville, AL, 35806
Huntsville, AL, 35806